Irene O. R.
- Country
- Spain
- Department
- Oncologia
Research Overview
- Phase 3 Randomized Study of Belzutifan Plus Zanzalintinib Versus Belzutifan Plus Placebo in Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy
- Phase II Evaluation of Axitinib Intensification Plus Standard of Care Versus Standard of Care Alone Post-Induction with Nivolumab and Ipilimumab in mRCC Patients
- Evaluation of BT8009 Monotherapy and BT8009 with Pembrolizumab Versus Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer
Data & Insights
Has run more than one trial at 98 of 243 partner sites.
Specializations
Oncology Focus
This investigator specializes in the treatment of urothelial cancer, with particular emphasis on advanced disease states including locally advanced and metastatic conditions.
- Urological Oncology
- Advanced Cancer Management
- Metastatic Disease Treatment
Their research encompasses innovative therapeutic approaches for urological malignancies.
Therapeutic Expertise
The investigator's work centers on combination therapy approaches in oncology, particularly exploring novel treatment combinations with immunotherapy.
- Targeted Therapies
- Immunotherapy Integration
- Combination Treatment Strategies
Their practice involves evaluating diverse therapeutic modalities for optimal patient outcomes.
Clinical Assessment
The investigator utilizes advanced methodologies for evaluating treatment responses, including RECIST criteria and sophisticated imaging assessments.
- Response Evaluation
- Disease Progression Monitoring
- Treatment Efficacy Assessment
Their expertise includes implementing standardized evaluation protocols in clinical practice.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.